The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAngle Share News (AGL)

Share Price Information for Angle (AGL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 19.25
Bid: 19.00
Ask: 19.50
Change: -0.25 (-1.28%)
Spread: 0.50 (2.632%)
Open: 19.50
High: 19.50
Low: 18.50
Prev. Close: 19.50
AGL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: Stocks make headway thanks to retailers

Thu, 05th Jan 2023 16:56

(Alliance News) - Stock prices in London closed higher, buoyed by optimism from strong retail updates, and shaking off hawkishness from the US Federal Reserve.

The FTSE 100 index closed up 48.26 points, 0.6%, at 7,633.45. The FTSE 250 ended up 72.36, 0.4%, at 19,463.43, and the AIM All-Share closed down just 0.19 of a point at 843.74.

The Cboe UK 100 ended up 0.8% at 764.81, the Cboe UK 250 closed up 0.9% at 16,978.11, and the Cboe Small Companies ended up 0.1% at 13,622.94.

US private employment rose by 235,000 jobs in December, according to figures from payroll firm ADP on Thursday.

The rise in private employment came well above market consensus, as cited by FXStreet, which had expected 150,000 jobs to be added.

In November, US private employers added 127,000 jobs.

December's increase was led by consumer-facing service industries, ADP said, with hiring strong across small and medium establishments. Large establishments, defined as companies with more than 500 employees, saw a drop in employment of 151,000 jobs.

Separately, the US Department of Labor reported that initial unemployment claims in the US fell in the week ending December 31.

The advance figure for seasonally adjusted initial claims was 204,000, representing a decrease of 19,000 from the previous week's figures of 223,000. Last week's figure was downwardly revised from 225,000.

The latest figures came below market expectations of 225,000.

The stronger-than-expected jobs print reignited fears over further hawkishness from the US Federal Reserve.

In minutes from its December meeting released on Thursday, the Federal Open Market Committee had said it was looking for further evidence that inflation was cooling. It highlighted its concern that the labour market remains "very tight", which is putting upward pressure on wages and prices.

In the US, the Dow Jones Industrial Average was down 1.1%, the S&P 500 was down 1.1% and Nasdaq Composite was 1.4% lower.

"Today's stronger employment data has therefore reduced fears about a downturn in employment and has raised worries that wage inflation could accelerate further and thus provide a major source of risk in the inflation outlook. Accordingly, traders have pushed up their expectations for the terminal interest rates in the US," explained Fawad Razaqzada, City Index and Forex.com market analyst.

The dollar firmed after the jobs data.

The pound was quoted at USD1.1890 at the close on Thursday in London, sharply lower compared to USD1.2054 at the close on Wednesday. The euro stood at USD1.0525, lower against USD1.0598. Against the yen, the dollar was trading at JPY133.89, sharply higher compared to JPY131.87.

In European equities on Thursday, the CAC 40 in Paris ended down 0.2%, while the DAX 40 in Frankfurt ended down 0.4%.

In the FTSE 100, Standard Chartered jumped 8.2%.

This follows a release from First Abu Dhabi Bank, which said it is no longer evaluating a takeover offer for FTSE 100-listed Asian-focused bank Standard Chartered PLC.

First Abu Dhabi Bank is a bank in the United Arab Emirates. It said it had previously been at the very early stages of evaluating a possible offer for Standard Chartered, but is no longer doing so.

Fellow Asia-focused lender, HSBC, also performed well, as Jefferies raised the stock to 'buy' from 'hold'. It rose 4.1%.

The investment banking and capital markets firm said HSBC is positively geared to the re-opening of the Chinese market as Covid-19 restrictions ease, along with the re-opening of the Hong Kong and mainland China border on Sunday this week.

It was also a strong day for bluechip retailers, as the first of the post-Christmas updates came in.

Clothing retailer Next rose 7.4%.

For the year ending in January 2023, Next increased its 2022 pretax profit guidance to GBP860 million, from GBP840 million. This would represent growth of 4.5% against the year prior, if achieved.

In the six months to December 30, Next said full price sales were up 2.2% against the previous year. In the three months to December 30, full price sales were up 4.7% against the year prior.

Clothing peers JD Sports, and Frasers were up 3.4% and 3.4%, respectively, in a positive read-across. Smallcap Superdry gained 8.6%.

B&M rose 0.5%.

The budget retailer said revenue in the 13 weeks to December 24 was up 12% to GBP1.57 billion from GBP1.40 billion a year prior, despite a challenging macroeconomic environment.

As a result, full-year adjusted earnings before interest, tax, depreciation and amortisation are now expected between GBP560 million to GBP580 million, coming above current analyst outlook consensus of GBP557 million.

The anticipated adjusted Ebitda would be a drop of at least 6.3% from GBP619 million in financial year 2022, however.

"B&M appeals to people who want to trade down from more expensive retailers, showing that the value proposition from a pricing perspective is a winning model in the current environment," AJ Bell's Russ Mould commented.

In the FTSE 250, Greggs was down 1.0%. The bakery chain reported strong double-digit growth in fourth quarter sales, despite the impact of adverse weather and rail strikes, as 2022 drew to a close.

In 2022, total sales were up 23% to GBP1.51 billion, from GBP1.23 billion the year prior. Like-for-like sales for 2022 were up 18%.

"Next, B&M and Greggs are united by having a presence on retail parks where business has been better than expected in general. Widespread train strikes will have prevented a lot of people from going to city centre shops, which means retail parks with their plentiful parking spaces have been the preferred alternative shopping destination," said Mould.

Wizzair added 13%, and easyJet rose 6.0%, after a positive update from airline peer Ryanair late Wednesday.

The Dublin-based low-cost airline said that it expects a stronger-than-expected third-quarter performance, due to strong pent-up travel demand over the holiday season.

The firm now expects full-year post-tax profit in the range of EUR1.33 billion to EUR1.43 billion, up from an initial forecast of EUR1 billion to EUR1.2 billion.

However, the budget airline noted in a statement that the reassessment was "heavily dependent" on avoiding further fallout from "adverse events" such as Covid or the ongoing war in Ukraine.

Meanwhile on AIM, Angle plunged 37%.

The Surrey, England-based medical diagnostics company said it expects "growth" in 2023, albeit significantly lower than market estimates, as it anticipates its operating loss to widen.

The Surrey, England-based medical diagnostics company noted it is on track to deliver anticipated cost savings of GBP2.6 million in 2023 and GBP4.0 million per year after that.

Describing 2022 as a "breakthrough year" with the first US Food & Drug Administration product clearance, Angle anticipates revenue to be just above GBP1 million, similar to GBP1.0 million posted for 2021. It estimates an operating loss of GBP22 million, in line with expectations and widened by 28% from GBP17.2 million in 2021.

Brent oil was quoted at USD78.48 a barrel at the London equities close Thursday from USD78.07 late Wednesday, while Gold fetched USD1,828.35 an ounce, down sharply from USD1,857.48.

In the global economic calendar, there's a Japan services PMI overnight, and then there will be German retail trade, manufacturing orders and manufacturing turnover at 0700 GMT.

There's the latest UK construction PMI at 0930 GMT, followed shortly after by EU data, including a flash inflation estimate, retail trade figures, and economic sentiment at 1000 GMT. The ISM US services PMI will come later in the day.

On the corporate side, there's a trading update from ten-pin bowling operator Ten Entertainment.

By Elizabeth Winter, Alliance News senior markets reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
22 Jun 2022 10:01

Angle wins cancer monitoring contract for Parasortix system

(Alliance News) - Angle PLC on Wednesday said it has secured further business with its "first large scale pharma services" customer.

Read more
16 Jun 2022 16:55

TRADING UPDATES: Valereum opens NFT market; Conygar considers raising

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
14 Jun 2022 20:13

IN BRIEF: Angle's Parsortix performs well on prostate cancer patients

Angle PLC - Surrey, England-based medical diagnostics company - Notes researchers at King's College London published data investigating the role of invasive cellular protrusion, known as invadopodia, activity in prostate cancer, and a potential role in the formation of circulating tumour cells. Researchers used Angle's Parsortix system's ability to isolate CTCs from the blood of prostate cancer patients. Parsortix system isolates CTCs in 94% of prostate cancer patients, showing some association with matrix degradation and invasive cellular protrusion formation. This may allow novel therapeutic development targeting the mechanisms of invadopodia and reducing metastatic spread of the cancer, it says.

Read more
30 May 2022 15:21

IN BRIEF: Angle partners with US urology group for Parasortix study

Angle PLC - Surrey, England-based medical diagnostics company - Establishes partnership with MidLantic Urology to evaluate the use of its Parasortix system in prostate cancer clinical studies. MidLantic is as an affiliate of special urology services provider Solaris, which has over 500 clinical urology providers across 179 locations in the US, with over 729,000 annual patients. Angle hopes the collaboration will "enable potential sales" to Solaris' patient base. The first study is expected to start in the third quarter of 2022, with results to be available in 2023.

Read more
27 May 2022 21:25

TRADING UPDATES: Savannah Energy to develop new projects in Chad

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
25 May 2022 21:19

IN BRIEF: Angle shares rocket as Parasortix receives US FDA approval

Angle PLC - Surrey, England-based medical diagnostics company - Receives approval from the US Food & Drug Administration for the use of its Parasortix system for use in metastatic breast cancer patients. Parasortix isolates circulating tumour cells from the blood which can aid in the diagnosis, characterisation and monitoring of cancer, and do so in a much less invasive fashion than traditional tissue biospy.

Read more
25 May 2022 17:06

LONDON MARKET CLOSE: Stocks rise ahead of US Fed meeting minutes

(Alliance News) - Stocks in London ended mostly higher on Wednesday as market participants look ahead to the latest minutes from the US Federal Reserve at 1900 BST.

Read more
20 May 2022 13:07

Angle's Parsortix to be used in 'significant' prostate cancer study

(Sharecast News) - Liquid biopsy company Angle announced on Friday that Prostate Cancer UK has approved funding for a "significant" clinical study at the Barts Cancer Institute of the Queen Mary University of London.

Read more
20 May 2022 09:48

IN BRIEF: Cancer study using Angle's Parasortix secures funding

Angle PLC - Surrey, England-based medical diagnostics company - Says Prostate Cancer UK has given a GBP750,000 grant for a clinical study at Barts Cancer Institute, Queen Mary University of London. The trial will follow 200 men with localised prostate cancer over five years, assessed using Angle's Parsortix system, in bid to see whether the cancer will eventually spread.

Read more
28 Apr 2022 16:10

EARNINGS UPDATES: Brave Bison notes first profit; Angle widens loss

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
21 Apr 2022 16:10

UK earnings, trading statements calendar - next 7 days

Friday 22 April 
Alphawave IP Group PLCFull Year Results
Petropavlovsk PLCTrading Statement
Record PLCTrading Statement
Serabi Gold PLCFull Year Results
Zinc Media Group PLCFull Year Results
Monday 25 April 
Access Intelligence PLCFull Year Results
Arecor Therapeutics PLCFull Year Results
Audioboom Group PLCFull Year Results
CentralNic Group PLCTrading Statement
Chapel Down Group PLCFull Year Results
Lok'n Store Group PLCHalf Year Results
Vector Capital PLCFull Year Results
Tuesday 26 April 
ASA International Group PLCFull Year Results
Associated British Foods PLCHalf Year Results
Billington Holdings PLCFull Year Results
Corero Network Security PLCFull Year Results
Focusrite PLCHalf Year Results
Futura Medical PLCFull Year Results
Gaming Realms PLCFull Year Results
Hochschild Mining PLCTrading Statement
HSBC Holdings PLCQ1 Results (at 0500 BST)
Immotion Group PLCFull Year Results
IWG PLCTrading Statement
Jupiter Fund Management PLCTrading Statement
Learning Technologies Group PLCFull Year Results
Loungers PLCTrading Statement
National Express Group PLCTrading Statement
Northcoders Group PLCFull Year Results
Nostrum Oil & Gas PLCFull Year Results
PureTech Health PLCFull Year Results
RWS Holdings PLCHalf Year Results
Taylor Wimpey PLCFull Year Results
Wednesday 27 April 
1Spatial PLCFull Year Results
AB Dynamics PLCHalf Year Results
Anglo Pacific Group PLCQ1 Results
Aveva Group PLCTrading Statement
City Pub Group PLCFull Year Results
Drax Group PLCTrading Statement
Fresnillo PLCQ1 Production Results
GlaxoSmithKline PLCQ1 Results
Go-Ahead Group PLCHalf Year Results
Lloyds Banking Group PLCQ1 Results
London Stock Exchange Group PLCTrading Statement
Network International Holdings PLCTrading Statement
Nichols PLCFull Year Results
Persimmon PLCTrading Statement
Primary Health Properties PLCTrading Statement
RPS Group PLCQ1 Results
WH Smith PLCHalf Year Results
WPP PLCTrading Statement
Yamana Gold IncTrading Statement
Thursday 28 April 
Angle PLCFull Year Results
Barclays PLCQ1 Results
Brave Bison Group PLCFull Year Results
C4X Discovery Holdings PLCHalf Year Results
Evraz PLCQ1 Results
Flutter Entertainment PLCQ1 Results
Glencore PLCTrading Statement
Howden Joinery Group PLCTrading Statement
HSS Hire Group PLCFull Year Results
Hurricane Energy PLCFull Year Results
Inchcape PLCTrading Statement
Indivior PLCQ1 Results
International Personal Finance PLCTrading Statement
J Sainsbury PLCFull Year Results
Keystone Law Group PLCFull Year Results
Lancashire Holdings LtdQ1 Trading Statement
Novacyt SAFull Year Results
PPHE Hotel Group LtdTrading Statement
Sanderson Design Group PLCFull Year Results
Schroders PLCTrading Statement
Smith & Nephew PLCQ1 Results
Spectris PLCQ1 Results
St James's Place PLCTrading Statement
Standard Chartered PLCQ1 Results
Unilever PLCQ1 Results
Whitbread PLCFull Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
1 Apr 2022 12:25

TRADING UPDATES: Yooma, Love Hemp in UK boost; Peel Hunt tops forecast

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
29 Mar 2022 19:29

IN BRIEF: Angle's Parsortix can help with cancer treatment options

Angle PLC - Surrey, England-based medical diagnostics company - Notes University of Maryland Marlene and Stewart Greenebaum NCI Comprehensive Cancer Institute has published results of work undertaken in preclinical models of triple-negative breast cancer. Findings show isolation of live circulating tumour cells from a simple blood draw, using Angle's Parsortix system, can provide rapid information on patient response to existing chemotherapy treatments that can target metastasis more effectively than tumour growth.

Read more
25 Mar 2022 18:51

TRADING UPDATES: Europa eyes fundraise; Eastinco extends long stop

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
18 Mar 2022 20:38

TRADING UPDATES: Angle US lab boost; Corcel to capitalise on nickel

(Alliance News) - The following is a round-up of updates by London-listed companies, issued this week and not separately reported by Alliance News:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.